With Northway Biotech's expertise in biologics manufacturing, Mallia aims to enter the multi-billion-dollar alopecia market by delivering a safe and effective topical sCD83 treatment designed to stimulate hair follicle formation and promote sustained hair growth.
Read More- STAR-1 topline results expected in March 2025 -
- Over 30 million acne patients seek treatment in the U.S. each year -
- Phase 2b for DMT310 achieved statistically significant results for all primary endpoints -
Read More